These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. GSK-3β inhibitor TWS119 alleviates hypoxic-ischemic brain damage via a crosstalk with Wnt and Notch signaling pathways in neonatal rats. Gao L; Yang L; Cui H Brain Res; 2021 Oct; 1768():147588. PubMed ID: 34310937 [TBL] [Abstract][Full Text] [Related]
18. Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia. Shimizu T; Dietz RM; Cruz-Torres I; Strnad F; Garske AK; Moreno M; Venna VR; Quillinan N; Herson PS Exp Neurol; 2016 Sep; 283(Pt A):151-6. PubMed ID: 27317297 [TBL] [Abstract][Full Text] [Related]
19. TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. Gao G; Wang W; Tadagavadi RK; Briley NE; Love MI; Miller BA; Reeves WB J Clin Invest; 2014 Nov; 124(11):4989-5001. PubMed ID: 25295536 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model. Ferreira AFF; Singulani MP; Ulrich H; Feng ZP; Sun HS; Britto LR Mol Neurobiol; 2022 Mar; 59(3):1543-1559. PubMed ID: 35000153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]